Remove Clinic Remove Health Science Remove Radiation Remove Radiation Oncology
article thumbnail

QT Imaging’s Breast Acoustic CT Scanner Used in Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy

Imaging Technology

This collaboration also addresses the ongoing clinical need in breast cancer therapy for the development of an inexpensive, robust, and accurate technique to identify the response, within weeks, of breast cancer to neoadjuvant chemotherapy. milla1cf Mon, 03/18/2024 - 07:00 March 18, 2024 — QT Imaging Holdings, Inc. ,

article thumbnail

QT Imaging to deliver Breast Acoustic CT scanner to research centers

AuntMinnie

The company is collaborating with the Department of Radiation Oncology and Radiation Treatment Program at the Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, and the University of Illinois, Urbana-Champaign. and Canada.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Using Recent Diagnostic Scans Can Substantially Cut Time to Treatment for Patients Needing Urgent Palliation

Imaging Technology

milla1cf Tue, 10/03/2023 - 11:11 October 3, 2023 — Using previously taken diagnostic computed tomography (CT) scans in place of CT simulation scans to plan simple palliative radiation treatments can substantially reduce the time some people spend waiting for urgent treatment, improving the patient experience, a new study suggests.

article thumbnail

The rise of theranostics: Part 2 -- Moving into communities

AuntMinnie

Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. When, in 2022, the U.S.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

article thumbnail

Radiology Trailblazers Named RLI Leadership Luminaries

Imaging Technology

Muroff, MD, FACR , the 2023 Leadership Luminary Award recipients for their exceptional lifetime achievements, innovation, leadership and service to the medical specialties of radiology or radiation oncology. He was the founding medical director of the Seattle/King County Clinic. Beauchamp Jr., Lawrence R.